MYC and acute lymphoblastic leukemia: In detail, treatment of pre-B ALL cells with the HDAC inhibitor panobinostat influences cell viability, induces apoptosis at increasing time treatment and leads to an increase in the expression levels of cyclin-dependent kinase inhibitors p21 and p27, correlating with the reduction of c-Myc and CDK4 mRNA expression level.